Crossmark

Integrated human organ-on-a-chip model for predictive studies of anti-tumor drug efficacy and cardiac safety

Crossref DOI link: https://doi.org/10.1039/D0LC00424C

Published Online: 2020

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Chramiec, Alan https://orcid.org/0000-0002-0883-0637
Teles, Diogo https://orcid.org/0000-0002-0235-6583
Yeager, Keith

Marturano-Kruik, Alessandro

Pak, Joseph

Chen, Timothy

Hao, Luke

Wang, Miranda

Lock, Roberta

Tavakol, Daniel Naveed

Lee, Marcus Busub

Kim, Jinho

Ronaldson-Bouchard, Kacey

Vunjak-Novakovic, Gordana https://orcid.org/0000-0002-9382-1574
Funding

Funding for this research was provided by:

National Heart, Lung, and Blood Institute (HL076485)

National Science Foundation (16478)

National Cancer Institute (CA013696, CA249799)

National Institute of Biomedical Imaging and Bioengineering (EB025765, EB027062)

Center for Scientific Review (S10OD020056)

Fundação para a Ciência e a Tecnologia (105819)
License Information

Accepted Manuscript valid from 2021-09-04
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Alan Chramiec (ORCID)

: Alan Chramiec (ResearcherID)

: Diogo Teles (ORCID)

: Gordana Vunjak-Novakovic (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 26 April 2020; Accepted 31 August 2020; Accepted Manuscript published 4 September 2020; Advance Article published 21 September 2020; Version of Record published 24 November 2020